Bioequivalence study between two Albendazole 400 mg tablets in healthy adult participants under fed conditions

Trial Identifier: 221030
Sponsor: GlaxoSmithKline
Start Date: August 2023
Primary Completion Date: September 2023
Study Completion Date: September 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
India Ahmedabad, India, 382481